Press releases

One mutation – one medicine

Prof. Dr. Matthis Synofzik develops tailored therapies for certain rare gene mutations. The German TV channel ZDF has now reported on the treatment of 5-year-old Poyraz, a patient with ataxia teleangiectasia. He is the first to be treated with this novel gene therapy in Tübingen.

To the media report

Read our press release on the therapy study

(Both in German only)

Image: Ingo Rappers / HIH

Press contact
Press contactDirector of Communications
Silke DutzTelefon 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen